Pearson J D
Centre for Cardiovascular Biology & Medicine, King's College London, UK.
Baillieres Best Pract Res Clin Haematol. 1999 Sep;12(3):329-41. doi: 10.1053/beha.1999.0028.
The endothelium is pivotal in the control of haemostasis and thrombosis because it is the primary source of many of the major haemostatic regulatory molecules. Healthy endothelial cells, unlike extravascular cells, are anticoagulant and antithrombotic. This is due to the regulated secretion of antiplatelet agents, including prostacyclin and nitric oxide. Following vessel injury, platelet adhesion to exposed matrix requires von Willebrand Factor, another endothelial cell product. Local generation of thrombin causes a series of receptor-mediated endothelial cell functional responses, while the surface of the endothelium is additionally the site for inactivation of thrombin by antithrombin, and its conversion to a coagulation inhibitor by interaction with thrombomodulin. Endothelial cells are also the source of circulating tissue-type plasminogen activator and its inhibitor, and Tissue Factor pathway inhibitor. In disease states, many of these endothelial cell properties are perturbed towards a more procoagulant and prothrombotic phenotype.
内皮在止血和血栓形成的控制中起关键作用,因为它是许多主要止血调节分子的主要来源。与血管外细胞不同,健康的内皮细胞具有抗凝和抗血栓形成作用。这是由于抗血小板剂(包括前列环素和一氧化氮)的调节性分泌。血管损伤后,血小板与暴露的基质黏附需要血管性血友病因子,这是内皮细胞的另一种产物。局部生成的凝血酶会引发一系列受体介导的内皮细胞功能反应,而内皮表面还是抗凝血酶使凝血酶失活以及凝血酶与血栓调节蛋白相互作用转化为凝血抑制剂的场所。内皮细胞也是循环组织型纤溶酶原激活物及其抑制剂以及组织因子途径抑制剂的来源。在疾病状态下,这些内皮细胞特性中的许多都会向更具促凝和促血栓形成的表型转变。